Froimson Mark 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 15, 2018
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Award
Common Stock
2018-06-13+782→ 882 total - Award
Stock Option (Right to Buy)
2018-06-13+4,693→ 4,693 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (4,693 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.